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CHAPTER - 1 
INTRODUCTION [1-4] 
       Herbal medicine referred to as herbalism or botanical medicine is the use of 
herbs for their therapeutic or medicinal value. An herb is a plant or plant part valued 
for its medicinal, aromatic qualities. 
       Plants produce and contain a variety of chemical substances that act upon the 
body. A herbolist uses the leaves, flowers, stems, berries and root of plants to prevent, 
relieve and treat illness. From a scientific perspective many herbal treatments are 
considered experimental. The reality is however, that herbal medicine has a long and 
respected history. Many familiar medications of the twentieth century were developed 
from ancient healing traditions that treated health problems with specific plants. Today 
science has isolated the medicinal properties of a large number of botanicals and their 
healing components have been extracted and analysed. Many plant components are 
now synthesized in large laboratories for used in pharmaceutical preparations.  
      World health organization (WHO) has estimated that 4 billion people, 80% of 
the world population, presently use herbal medicine for some aspect of primary 
healthcare. Herbal medicine is a major component in all indigenous peoples traditional 
medicine and a common element in Ayurvedic, Homeopathic, Naturopathic, 
traditional oriental and native American Indian medicine. 
        WHO notes that of 119 plants derived pharmaceutical medicines i.e. about 
74% are used in modern medicine in ways that correlated directly with their traditional 
uses as plant medicines by native cultures. Major pharmaceutical companies are 
currently conducting extensive research on plant materials gathered from the rain 
forest and other places for their potential medicinal value. 
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        Rather than using a whole plant, a pharmacologist identifies, isolates, extracts 
and synthesizes individual components thus capturing the active properties. This can 
create problems because in addition to active ingredients, plants also contain minerals, 
vitamins, volatile oil, glycosides, alkaloids, bioflavonoids and other substances that are 
important in supporting particular herbs medicinal properties.        
Doctors and government agencies want to see scientific studies before 
recognizing the effectiveness of plant as medicine. Yet even though substantial 
research is being done in other countries, drug companies and laboratories in the 
United States so far have not chosen to put much money or resources into botanical 
research. The result is that herbal medicines do not have the same place of importance 
or level of acceptance in US as it does in other countries. 
HEART FAILURE 
             Interruption of blood supply to a part of the heart causing heart cells to die. 
This is commonly due to occlusion of coronary artery following the rupture of a 
vulnerable atherosclerotic plaque, which is an unstable collection of lipids and white 
blood cells in the wall of an artery. The resulting ischemia and ensuring oxygen 
shortage, if left untreated for a sufficient period of time can cause damage or death of 
heart muscle tissue. Classical symptoms of acute myocardial infarction are sudden 
chest pain, shortness of breath, nausea, vomiting, palpitation, sweating, anxiety. 
Etiology 
A).Depressed ejection fraction: 
1. Coronary artery disease      – myocardial infarction, myocardial ischemia. 
2. Chronic pressure overload  – hypertension,obstructive valvular disease. 
3. Chronic volume overload – regurgitant valvular disease, intracardiac shunting. 
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4. Non ischemic dilated cardiomyopathy – familial genetic disorder, infiltrative 
disorder toxic  or drug induced damage, metabolic disorder, viral, chronic disease. 
4. Disorder of rate and rhythm – chronic bradyarrhythmia chronic tachyarrhythmia. 
B).Preserved hypertrophy – infiltrative disorders (Amyloidosis, sarcoidosis) storage 
disease( haemochromatosis). Paste from padma book 
CARDIOTOXICITY 
         Cardiotoxicity is a condition in which the damage of heart muscle occur and the 
heart may not be able to pump the blood throughout the body. Severe cardiotoxicity 
leads to cardiomyopathy 
CARDIOTOXIC AGENTS 
           A variety of pharmacologic agents may damage the myocardium acutely, 
producing a pattern of inflammation(myocarditis) or may even lead to chronic damage 
as seen in dilated cardiomyopathy. Certain drugs may produce ECG abnormalities 
alone while others may precipitate CHF and death. Some of the cardiotoxic agents 
includes doxorubicin, daunorubicin, cyclophosphamide, phenothiazine, chloroquine, 
cocaine, tratuzumab etc. 
         Doxorubicin is one of the most active cytotoxic agents in currenr use. It has 
proven efficacy in varies malignancies either alone or combined with other cytocidal 
agents. 
         It  produces severe cardiomyopathy and heart failure  in doxorubicin treated 
cancer patients hence its use is being limited. It causes lipid peroxidation of the 
myofibre membranes resulting in myofibre swelling, vacuolization, fatty changes, 
cytolysis, systolic dysfunction and ventricular tachyarrhythmic occurs in a dose 
dependent manner. 
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CARDIOPROTECTIVE HERBS 
 The cardioprotective herbs have been extensively investigated chemically and 
evaluated clinically for its beneficial cardiovascular properties. The cardio protective 
herbs  support the heart due to the high content of bioflavonoid. It increases the body’s 
ability to utilize oxygen, and the heart’s ability to utilize calcium. 
     Most of the cardio tonic herbs produced bradycardia, significant decrease of 
arterial blood pressure both in normotensive and hypotensive rats and antiarrhythmic 
activity in all experimental models of arrhythmia. The cardio tonic herbs also show 
strong negative chromotropic, positive inotropic and coronary dilating effects. 
      Several herbs offer potential for cardiovascular conditions including venous 
insufficiency, intermittent claudicating, hyperlipidemia, hypertension and congenstive 
heart failure. In-vitro evidence suggest garlic reduces blood pressure by inhibiting 
platelet NO synthase. The mechanism of Gingko biloba improving vascular health 
include free radical scavenging, antiplatelet actions, anti-inflammatory actions, 
vasodilations and decrease blood viscosity. 
    Howthorn is a spiny shrub and contains flavonoids and oligomeric 
procyanthins which are used for antioxidants, inotropic, vasodilatory and 
antihyperlipidemic actions and as well as decrease capillary permeability.Positive 
inotropic action may also be due to inhibition of myocardial Na
+
/K
+
 ATPase which is 
an integral membrane enzyme that maintain cardiac resting potential. It is also 
decreases blood pressure which results in an increase in exercise tolerance during the 
early stage of  congestive heart failure. 
   Bioflavonoids of herbs used for dilating both peripheral and coronary blood 
vessels leading to its use in angina. Procyanidins contents is claimed to support the 
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vasorelaxant effects. Glycoside component of Hawthorn’s has also been reported to 
increase vagal tone of the heart. Ma Huang (Ephedra sinica) is a natural source of 
ephedrine and has potent sympathomimetic activity. Dang-Gui Buxue tang enhance 
myocardial mitochondrial as well as red blood cell glutathione status, increasing 
resistance to oxidative stress.  Terminalia arjuna is a reputed heart friendly herb that 
has been in use for over 2500 B.C. It is useful in hypertension, angina, heart attacks, 
hypercholesterolemia and hyperlipidemia. 
    There are lots of potential of using plants as cardioprotective agents against 
toxic substances, and anticancer agents etc. Hence an attempt is made to study whether 
the little known herb Justicia glauca will be useful for treating the above diseases.  
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CHAPTER - 2 
REVIEW OF LITERATURE 
PHARAMACOGNOSY 
  Sanchez E et al., (1985) have studied the pharmacognostical parameters in     
several medicinal plants namely Artemisia abortamun,Calend officinalis,Cymbopogan 
citratus, Justicia pectoralis,Ocimum basilica,Rhoeo spathaceae and Ruta graveolens
.[5]
 
              Anuradha U et al., (1988) have studied six species namely Glossocardia 
bosvallea, Justicia procumbens, Haplanthus verticillaris, Oldenlandia corymbosa, 
Peristrophebicaly cultata and Rrungia repenes used as ‘pittapapada’ by local people of 
pune and neighboring districts.
 [6]
 
La serna B et al., (1989) have reported water content (81%), total nitrogen 
(2.5%) and chemical constituents of the different extracts of the plant. Decoction of the 
plant is widely used as sedative in folk medicine. 
[7]
 
PHYTOCHEMISTRY 
           Ghosal S et al., (1979) have isolated three known lignans sesamin,asarinin and 
sesamolin and new lignan simplexolin. Screening tests of the lignans conducted on 
laboratory animals indicated significant CNS activity. 
[8]
 
            Olaniyi A et al., (1980) have isolated three lignans namely helioxanthin, 
justicinol and (+)-isolariciresinol from leaves of Justicia flava. 
[9]
 
            Ghosal S et al., (1981) have isolated a new triterpenoid saponin, 
justiciasaponin-I from the petroleum ether extract of the whole plant and identified as 
oleanolic acid -3-o-β-D-glucopyranosyl-4-o-ferulate. 
[10]
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          Rao B et al., (1984) have isolated several compounds belonging to the class of 
steroids, terpenes, coumarins, glucosides, alkaloids and flavonoids from a number of 
Indian medicinal plants Ipomoea digitata, Ipomoea kentrocaulos, Artabotrys 
odoratissimus, Michelia champaca, Justicia glauca, Premna integrifolia, Premna 
foetida, Euphorbia splendens.
[11]
 
           Joseph H et al., (1988) have isolated justicidin B,a 1-aryl-2,3-naphthalide lignan 
from ethanolic extract of whole plants of  Justicia pectoralis.
[12]
 
           Trujillo J M et al., (1990) have isolated two new lignans namely J1,J2 from 
leaves of Justicia hyssopifolia.The latter as a β-D-glucoside together with the known 
lignans helixanthin, justicidin E, gadain, cubebin and sesamin
.[13]
 
Chen CC et al., (1996) have isolated nine known arylnaphthalide lignans,            
Neolignans A (1), justicidin B (2),justicidin A (3), taiwanin E methyl ether                                  
(4), neojusticindin B (5), chinensinaphthol methyl ether (6),Taiwan E (8), 
chinensinaphthol (9), and diphyllin (10), and a new arylnaphthalide lignans.
[14]
 
Chen C C et al., (1998) have reported the isolation of diarylbutane lignans from 
Justicia procumbens namely Justicidin A, B, C. The structures were established by 
spectral analysis
. [15]
 
  Rajasekar D et al., (2000) have isolated prostalidin D, a new arylnaphthalide 
lignan from Jusicia diffusa var, prostata. Prostalidin D (1) and seven were isolated from 
Justicia diffusa var. prostata and were identified by direct comparison with authentic 
samples 
[16]
 
Perez JA et al., (2004) have described the isolation of a novel p-quinone-lignan 
derivatives from Justicia hyssopifolia. An unknown, previously unreported p-quinone 
REVIEW OF LITERAUTRE 
 
 
Department of Pharmacognosy, MMC  
 8 
 
lignan compound called justicidone along with known savinin from Justicia 
hyssopifolia (Acanthaceae). 
[17] 
Srinivastava S K et al., (2007) have reported the isolation of β-sitosterol from 
petroleum ether extract and choline from the ethanolic extract of Justicia aurea 
(Acanthaceae) 
[18] 
PHARMACOLOGY 
Mills J et al., (1986) have reported aqueous and organic extracts of Justicia 
pectoralis influenced the wound healing process. Coumarin isolated from the little plant 
showed attenuated inflammatory process and significantly enhanced wound healing in 
the experimental rats. 
[19]
 
Mruthyunjayaswamy BHM et al., (1998) have screened the alcoholic extract of 
Justicia procumbens for in-vitro anti-inflammatory activity in albino rats at a dose of 
100mg/kg body weight. The activity has been attributed to the presence of steroids and 
flavonoids in the extract 
[20]
 
              Day SH et al., (1999) have done the cytotoxic activity against several cell 
lines. Justicidin A showed potent cytotoxic effect against T-24, caski, sitta, HT-3, PLC/ 
PRF/5 and cells in-vitro. Two new naturally occurring 1-aryl-2,3 aphthalide lignans, 
cilinaphthalide A (C22H20O7, m.p 221-2
ο
C) and cilinaphthalide B (C23H22O7, m.p. 
202.5-203.5
ο
C) and nine compounds were isolated from the whole plants of  Justicia 
ciliata
[21]
. 
            Day SH et al., (2000) have evaluated the anti-inflammatory effect of (two new 
lignan glycosides 4-O-{α-arabinosyl-1) (1-2)-β-D-xylopyranosyl-(1-5-β-D-
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apiofuranosyl) diphyllin(1) named ciliatoside A (1), 4-O-(β-D-apiofuranosyl-(1-3)-α-L-
arabinopyranosyl (1-2)β-D-xylo pyranosyl (1-5)-β-D-apiofuranosyl) diphyllin (2) 
named ciliotoside B (2) isolated from Justicia ciliate
[22]
 
Mohaghezadesh A et al., (2002) have reported arylnaphthalene lignans from in-
vitro cultures of Linum austrianum. Lignans and their derivatives find application in 
cancer chemotherapy. Callus suspension and normal and hairy root cultures of Linum 
austrianum produced a new arylnaphthalene dioxy-2, 7-cycloligna-7, 7’-dieno-9,9’-
lactone together with Justiciadin B
[23]
 
Day SH et al., (2002) have studied the potent cytotoxic effects against number 
of cancer cells in-vitro by using new lignan glycoside.4-O-α-L- arabinosyl–(1-2)-β-D-
apiofuranosyldiphyllin (2) named procumbenoside A and 11 known compounds were 
isolated from methonolic extract of the air dried whole plant of  Justicia procumbens
[24]
. 
            Telefo PB et al., (2003) have reported the oestrogenicity and effect on hepatic 
metabolism of the aqueous extract of leaf mixture of Aloe buttneri, Dicliptera 
ventricullata, Hibiscus macranthus and Justicia insularis. The aqueous extracts of leaf 
mixture showed the induced effect on ovarian and uteri weight as well as serum and 
ovarian oestrodial. Significant decrease in liver of aminopyrin N-demethylase activity 
was noticed in treated animals 
[25]
 
Woradulayapinij W et al.,(2005) have studied the in-vitro HIV type 1 reverse 
transcriptase inhibitory activities of Thai medicinal plants and Canna indica L. 
rhizomes. Water and 80% ethanol extract of 20 Thai medicinal plants used to treat 
AIDS were tested for their HIV type 1 reverse transcriptase inhibitory activity. The 
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water extracts of Ipomea carnea subsp. Fistulosa (aerial parts), Justicia gendarussa 
(aerial parts) showed HIV-1 RT inhibitory ratio (% IR) higher than 90% at a 200µg/mL 
concentration 
[26]
 
Ratnasooriya WD et al., (2007) have reported that the aqueous leaf extract of  
Justicia gendarussa (Acanthaceae) significant antinoceptive action when tested in mice. 
The aqueous leaf extract also showed strong antioxidant activity 
[27]
 
Bedoya L M et al., (2008) have reported the Guatamalan plant extracts as 
virucides against HIV -1 infection. Three Guatamalan plants extracts Justicia reptans 
(Acanthaceae), Neurolaene lobata (Astraceae) and Pouteria viridis (Sapotaceae) were 
used for classical antiviral assay and found to inhibit  HIV replication. The active 
fractions were non-toxic in-vitro and also inhibited other enveloped virus 
[28]
 
Dwivedi et al., (2008) have reported the use of Justicia adhatoda in traditional 
herbal remedies from the Vindhaya region of Madhya Pradesh in treatment of viral 
hepatitis 
[29]
 
Paval J et al., (2009) have compared the anti-arthritis activities of the plants 
Justicia gendraussa Burm. F and Withania somnifera Linn in arthritis induced in male 
albino rats using Freund’s complete adjuvant and bovine type II collagen 
[30]
 
Sathianarayanan S et al., (2009) have studied the antimicrobial activity of 
various extracts of Justicia transquarberiensis against Gram positive, Gram negative 
bacteria, streptococci aureus, Basillus subtilis, E. coli and antifungal activity was also 
studied
[31]
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Umar S et al., (2010) have studied hepatoprotective activities of two Ethiopian 
medicinal plants namely Justicia schimperiana and Verbascum sinaiticum which are 
used in Ethiopian traditional medicinal practices for the treatment of liver diseases 
[32]
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CHAPTER - 3 
AIM AND SCOPE OF THE PRESENT STUDY 
The ethno medical information reveals that the species of Justicia possessed a 
wide spectrum of activity which included anticancer, antirheumatic, antisyphilitic, 
diuretic, antitubercular, antimalarial, laxative, and sedative, cardio protective, 
antifungal and antibacterial activities. According to Siddha system of medicine, leaves 
of Justicia adathoda possess cardio protective property.  
The ethno medical information also revealed that the fruits of Justicia glauca 
were found to possess antibacterial and antifungal activities. The phytochemical 
studies on the leaves have reported for the presence of flavonoids, tannins, alkaloids, 
sterols and carbohydrates.  
The cardioprotective, anticancer, antibacterial, antifungal and antioxidant have 
not yet been reported so far on the whole plant of Justicia glauca 
Hence the present work has been designed to carry out the following studies on 
the leaves Justicia glauca Rottler. 
1. Pharmacognostical studies on the whole plant. 
2. Preliminary phytochemical screening on the extracts of Justicia  
            glauca  
3. Quantitative estimation of secondary metabolites. 
4. Phytochemical evaluation of whole plant ethanolic extract by  
  TLC and HPTLC studies. 
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5. Screening of the ethanolic extract of the whole plant for 
following  
           pharmacological activities. 
 In vitro antioxidants activity 
• DPPH radical scavenging activity 
• Nitric oxide scavenging activity 
• Phosphomolybdenum method 
 Cardioprotective effect of leaf extract of Justicia glauca on 
doxorubicin induced cardiotoxicity in rats. 
 Antibacterial activity  
 Antifungal activity 
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CHAPTER - 4 
PLANT PROFILE 
BOTANICAL SOURCE  :   Justicia glauca Rottler 
FAMILY                        :    Acanthaceae  
Justicia glauca is an undershrub found in the foothills of Peninsular India. The 
leaves are elliptic-ovate, 3-5 cm long and 2-3 cm wide. The flowers appear during 
July-December.  
SYSTEMATIC POSITION 
[33,34]
 
Domain                 :Eukaryota 
Kingdom      : Plantae 
Subkingdom        : Viridaeplantae 
Phyllum        : Tracheophyta 
Subphylum        : Euphyllophytina 
Infraphyllum       : Radiatopses 
Class                  : Vagnoliposida 
Subclass                         : Asteridae 
Super order                      :Lamianae 
Order                              : Lamiales 
Family                            : Acanthaceae 
Subfamily                      : Acanthoideae 
Tribe                              : Ruellieae 
Subtribe                         : Justicinae 
Genus                            : Justicia 
Specific epithet             : Glauca-Rottler 
Division                        : Magnoliopphyta 
Genies                          : Justicia  
Species                         : Glauca 
SYNONYM: 
 Galucous justicia 
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GEOGRAPHICAL DISTRIBUTION: 
  Justicia glauca grows in waste lands and slopes. It is very common near 
foothills to 1000 (1750) m. 
HABIT AND HABITAT: 
 Justicia glauca is an undershrub found in the foothills of India. 
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CHAPTER - 5 
PHARMACOGNOSTICAL STUDIES 
A detailed pharmacognostical evaluation gives valuable information regarding 
the morphology, microscopical and physical characteristics of crude drugs. They can 
be used for the botanical identification of the plant at a future date. Many 
pharmacognostic studies have been carried out on many important drugs, and the 
resulting observations have been incorporated in various herbal pharmacopoeias. 
There are a number of crude drugs where the plant source has not yet been 
scientifically identified. Hence pharmacognostic study gives the scientific information 
regarding the purity and quality of crude drugs. 
SECTION- A 
MORPHOLOGICAL STUDIES  
Morphological studies include aspects of the outward appearance (shape, 
structure, colour and pattern) as well as the form and structure of the internal parts like 
cells etc. Some of these gross morphological characters of drugs such as shape, size, 
margin, apex and venation are identification features of drugs. These features give 
valuable information about the drugs. 
MATERIALS AND METHODS 
Collection of plant material
[35-40]
 
             The plant specimens were collected from Yannaimalai in Madurai which is 
10km from Madurai Medical College. The specimen was authenticated by the 
Director, The Rapinat Herbarium and Centre for Molecular Systematic, St. Joseph’s 
College Campus, Tiruchirappalli-620002. A voucher specimen is kept in the 
Department of Pharmacognosy, College of Pharmacy, Madurai Medical College, 
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Madurai (Fig.1). The various aerial parts of Justicia glauca collected for 
macroscopical evaluation were leaves, flowers etc. The photographs of the 
macroscopic features of the plant are shown in Fig. 2.1 to 2.3 
OBSERVATIONS AND DISCUSSION 
Leaves (Fig.2.1) 
[33] 
 The leaves are elliptic-ovate, 3-5cm long and 2-3cm wide. 
 Flowers (Fig.2.3) 
The flower spikes are erect, about 10cm long. Bracts are broadly ovate, and 
bracteoles are linear. The flowers are pink, with 5 lance-shaped sepals which are 3-
nerved and have minute hair on them. The flowers are 8 x 3mm across. The flowering 
season is between July and December. 
Fruits 
The capsule is 1cm long and 0.5cm wide, pointed at the tip, tapering into a 
solid beak below.  
 The above morphological studies such as shape, size, margin, apex of the 
leaves and flowers and venation pattern of the leaves are identification features of 
drugs. These features give valuable information about the drugs. 
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SECTION - B 
MICROSCOPICAL STUDIES 
[37,38, 39] 
The microscopical study of organized crude drugs is an important parameter 
for evaluation. The microscopical evaluations allow more detailed examination of the 
plant material to identify the organized drug by its histological character. It provides 
detailed information about the crude drugs by virtue of its property to magnify the fine 
structures of minute objects to be visualized and there by confirm the structural details 
of the plant drugs under evaluations. It can also be used in the determination of the 
optical as well as micro chemical properties of the crude drug confirmation study. 
MATERIALS AND METHODS 
Collection of specimens 
 The root, stem, leaves and flowers of the plant were subjected to 
microscopical evaluation. The samples were cut and removed from the plant and fixed 
in FAA (formalin, 5mL; acetic acid, 5mL; ethyl alcohol, 90mL). After 24h of fixing, 
the specimens were dehydrated with graded series of t-butyl alcohol [37]. Infiltration 
of the specimens was carried by gradual addition of paraffin wax (M.P-58-60
o
C) until 
TBA solution attained super saturation. The specimens were cast in to paraffin blocks. 
Sectioning  
 The rotary microtome was used to section the paraffin embedded specimens 
into sections of 10-12µm thickness. They were then placed on a slide and de-waxing 
of the sections was carried out by customary procedure [38]. The sections were stained 
with toluidine blue [39] since it is a polychromatic stain. The dye rendered pink color 
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to the cellulose walls, blue to the lignified cells, violet to the mucilage, and blue to the 
protein bodies and also stained with safranin.  
Leaf clearing 
Two methods were used for studying the stomatal morphology, venation 
pattern and trichome distribution. The paraffin embedded leaf was used for para-
dermal sections. From these sections, the epidermal layers as well as vein islets were 
studied. Another method employed was clearing leaf fragments by immersing the 
material in alcohol (to remove chlorophyll) followed by treating with 5% sodium 
hydroxide. The material was rendered transparent due to loss of cell contents. 
Epidermal peeling by partial maceration employing Jeffrey’s maceration was also 
done. Glycerin mounted temporary preparations were made for cleared materials.   
For study of elements of xylem, small fragments of stem and root were 
macerated with Jeffery’s maceration fluid.  
Powdered materials of different parts were cleared with sodium hydroxide and 
mounted in glycerin medium after staining. Different cell component were studied and 
measured. 
Photomicrographs 
The photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observations bright field was used and for the study of 
starch grains and lignified cells, polarized light was employed. Since these structures 
have birefringent property, under polarized they appear bright against dark 
background. The magnifications of the anatomical features are indicated by the scale-
bars in the photograophs. The microscopic features are presented in Fig. 3 to 15. 
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OBSERVATIONS AND DISCUSSION 
Midrib of the leaf (Fig. 3.1, 2) 
 The midrib consists of adaxial projection of thick broad hump and abaxial wide part. It 
is 400µm thick; the abaxial hump is 100×200µm and the abaxial part is 300µm wide. The 
midrib consists of thick and prominent epidermal layer of square shaped cells with prominent 
cuticle. Some of the cells are modified into lithocysts. The adaxial cone includes a cluster of 
collenchyma and a layer of palisade cells. Remaining ground tissue is parenchymatous; the 
cells are wide thin walled and compact. The vascular strand is broadly triangular with 
semicircular base. The xylem elements are arranged straight, short parallel lines. Phloem 
occurs in small clusters beneath the xylem strands. 
Lamina (Fig. 4.1) 
The lamina is distinctly dorsiventral and the surfaces are even and smooth. It is 160µm 
thick. The adaxial epidermis consists of thick epidermal layer of wide rectangular cells with 
prominent cuticle. The adaxial epidermis bears stomata. The cells are 20µm thick. The abaxial 
epidermal cells are thin, narrowly rectangular or square shaped. These are shallow depressions 
in which are located glandular trichomes. The gland is capitate type. It consists of short stalk 
that is embedded in the epidermal layer. The body is sub spherical, two or four celled and 
possess prominent nuclei (Fig. 4.1). The gland is 15×25µm in size. The mesophyll tissue is 
differentiated into adaxial single vertical narrow columnar palisade cells which have wide gaps 
in between the palisade. Spongy parenchyma cells include three or four layers of thin lobed 
cells with large air chambers. 
Leaf – margin (Fig. 4.2) 
The marginal portion of the leaf is blunt and the end portion is semicircular, it is 
120µm thick. The epidermis of the lamina continues in the margins; the epidermal cells 
become smaller and thick walled. The palisade and spongy mesophyll tissues remain distinct; 
but the cells are more compact and rigid. 
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 Some of the epidermal cells become highly dilated into long canal like cavities. 
Within these elongated cavities occur long, thin cylindrical cystoliths. The cavities possessing 
the cystoliths are called lithocysts (Fig. 5.1). In sectional view the leaf the litho cysts appear 
dilated circular cells with circular dense cystoliths. (Fig. 4.2) 
Stomata and epidermal cells (Fig. 5.2) 
 When viewed in paradermal sections, the epidermal cells of both upper and lower 
layers are highly wavy and the cells appear amoeboid in outline because the anticlinical walls 
are thick and undulate. The stomata are exclusively diacytic type, in which these are two 
subsidiary cells with their common wall lying at right angles to the long axis of the guard cells 
(Fig. 5.2) 
Venation pattern (Fig. 6.1, 2) 
 The veins are thin and slender. They form less dense reticulate venation system and 
the vein- islets are less distinct. When the islets are distinct they are variable in size and shape. 
The islets are wide with thin vein boundaries. The vein terminations are long thin and 
undulate. They are unbranched or branched once; branching is irregular. (Fig. 6.2) 
Petiole (Fig. 7.1, 2) 
 The petiole is semicircular with flat adaxial slide. It consists of a thick epidermal layer 
of squarish cells. The ground tissue is homogeneous and parenchymatous the cells are angular 
and compact. The vascular strand is broad slightly concave, measuring 50×350µm in size. The 
vascular strand in collateral; it includes parallel files of thick walled circular, fairly wide 
xylem elements the sieve elements of the phloem occurs in thin row beneath the xylem strand. 
 Stem (Fig. 8 & 9) 
 The stem is circular with shallow ridges and furrows. It is 1.9mm thick. The stem 
consists of a distinct epidermal layer of squarish cells. Some of the epidermal cells are dilated 
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and possess circular and chinate cystoliths. The cortex is wide and includes about five layers 
of collenchymas cells followed by five and six layers of wide thin walled compact parenchyma 
cells (Fig. 8.2). 
 The vascular system consists of a circle of six prominent collateral vascular bundles, 
the number of bundles corresponding to the number of ridges of the stem. The vascular 
segments are semicircular; the medullary rays in between the vascular segments have initial 
stage of secondary growth and origin of interfascicular cambium (Fig. 8.2): The vascular 
bundle have short parallel rows of wide angular thick walled xylem elements. On the outer 
portion of the xylem strands occur phloem elements. The phloem elements are small, diffuse 
and random in distribution. The pith is wide, homogeneous and parenchymatous. 
Root (Fig. 10.1, 2) 
 The roots of two different thicknesses are studied. In thin root measuring 1.4mm in 
diameter consists of thin periderm and thick solid vascular cylinder (Fig. 10.1, 2). The 
periderm is very thin comprising of two or three layers of compressed cells. The cortical zone 
is narrow and there are the three layers of parenchyma cells. Some of the cortical parenchyma 
cells are dilated into lithocysts possessing cystoliths. 
 Thick root measuring 3.2mm in diameter exhibits thick secondary growth (Fig. 11 & 
12). It consists of three or four layers of periderm, about six layers of tangentially elongated 
rectangular cortical cells with cystoliths and thick solid vascular cylinder (Fig. 10.1, 2). 
 The phloem zone is uneven in thickness; the phloem elements are fairly wide diffuse 
in distribution and have thick cell walls. (Fig. 12.1); the secondary xylem is thick, dense and 
solid; it exhibits two or three growth rings in the peripheral zone. The central zone has no 
growth rings. The growth rings are characterized by a single circle of wide vessels followed by 
very narrow vessels at the end of the growth rings (Fig. 11.1, 2; 12.2). The vessels are circular 
and thin walled; they are up to 70µm wide. Xylem fibers thick walled and lignified. 
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Powder microscopy 
 The powder consists of following elements. 
Epidermal trichomes (Fig. 11.1; 15.1) 
Long curved, multicellular, uniseriate unbranched nonglandular trichomes are 
common, the cells narrow and noded at the cross walls; the trichomes are upto 800 µm long. 
Parenchyma cells (Fig. 13.2) 
            Wide plates of parenchyma cells are frequently seen. The cells are rectangular or 
squarish. Their walls are thick. Some cell inclusions are seen in the cells. 
Fibres  (Fig. 13.1,2; 15.2)  
Narrow long liberiform fibres are abundant in the powder. They have thick walled and 
wide lumen. No pits are seen in the powder. The fibres are 300-380µm long and 10µm wide. 
Vessel elements (Fig.14 & 15) 
The vessel elements are unique. They are as long as the fibres and are very narrow 
resembling fibres. But the vessel elements have dense mutliseriate pits and oblique 
perforations at the ends. Long or short tails are also present in some of the vessel elements. 
The vessel elements are 200-350µm long. 
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                                                       SECTION – C 
QUANTITATIVE MICROSCOPICAL STUDIES 
[38,39, 40]
  
DETERMINATION OF LEAF CONSTANTS 
  The vein islet number, vein termination number, stomatal number and stomatal 
index were determined on fresh leaves by using standard procedures. 
Vein islet number and vein termination number:  
The term vein islet is used to denote the minute area of photo synthetic tissue 
encircled by the ultimate division of the conducting strands. The number of vein islets 
per square mm area is called vein- islet number.  Vein termination number may be 
defined as the number of vein terminations present in one square mm area of the 
photosynthetic tissue. 
Procedure  
The leaves were cut into small pieces on the lamina between midrib and the 
margin, cleared in chloral hydrate and mounted on a slide. The camera lucida and 
drawing board were arranged.  With the help of a stage micrometer, camera Lucida 
and microscope, 1mm square was drawn on the paper.  Then the stage micrometer was 
replaced by the sample slides and the veins were traced over the square. The vein islets 
and vein terminations were counted in the square.  Six such readings were taken and 
the average was calculated and the results were presented in
 
Table 1 
Stomatal Number and Stomatal Index  
The average number of stomata per square mm area of epidermis of the leaf is 
called stomatal number. The stomatal index is the percentage of the ratio of number 
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of stomata to the total number of epidermal cells, each stoma beings counted as one 
cell. The stomatal index was calculated using the formula 
S.I =


 ×100  
Where S = number of stomata per unit area; E = number of epidermal cells in the same 
unit area 
Procedure 
The upper and lower epidermal peelings of the leaves were mounted on a slide.  
A camera lucida and stage micrometer were used to draw 1mm square was on a paper.  
The stage micrometer was replaced by the preparation slide. Then the preparations 
were observed under microscope and the stomata were marked in that unit area. The 
number of stomata present in unit area was calculated.  Six such readings were taken 
and the average of stomatal number was calculated and presented in Table 1.  
       The procedure adopted in the determination of stomatal number was followed for 
the determination of stomatal index but the preparation was observed under high 
power.  The epidermal cells and the stomata were counted.  From these values the 
stomatal index was calculated and the results obtained are tabulated in Table 1. 
RESULTS AND DISCUSSION 
 From Table 1, it can be seen that the stomatal number in upper epidermis was 
28.84±0.61 while it was 58.34±0.92 for the lower epidermis. The vein islet number 
was 10.84±0.41 while the vein termination number was 21.17±0.31. The stomatal 
number in the lower epidermis was nearly twice the value seen in the upper epidermis. 
The determination of the leaf constants helps in the identity of this plant from the other 
species of the genus Justicia. 
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Table 1: Quantitative microscopical 
parameters of the leaf of Justicia glauca 
 
S. No. 
 
Parameters* Values obtained* 
1 Vein islet number 
 
10.84±0.41 
2 Vein termination number 
 
21.17±0.31 
3 Stomatal number  in upper 
epidermis 
28.84±0.61 
4. Stomatal number  in lower 
epidermis 
58.34±0.92 
5. Stomatal index in upper 
epidermis  
8.17±0.31 
6. Stomatal index in lower 
epidermis  
13.17±0.61 
*Mean of 6 readings ± SEM 
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SECTION - D 
PHYSICAL PARAMETERS 
[40-42]
 
ASH VALUES 
   The ash values were determined by using air dried powdered leaves as per the 
official method. The total ash, acid insoluble ash and water soluble ash were 
determined.  
(A ) Total ash 
Procedure    
An accurate quantity of 2g of the whole plant powder was weighed and 
transferred into a tarred nickel crucible and scattered in a fine even layer on the bottom 
of the crucible and incinerated by gradually increasing the heat not exceeding 450˚C 
[dull red heat] until free form carbon. Then it was cooled and weighed for constant 
weight. The percentage of ash with reference to the air dried drug was calculated. The 
values were determined in triplicate. The results are presented in Table 2. 
(B) Acid insoluble ash 
           Crude drugs containing larger quantity of calcium oxalate can give variable 
results depending upon the conditions of ignition. Treatment of ash with HCl leaves 
virtually only silica. It is necessary to use ash less filter paper during filtration and 
subsequent incineration, to limit the error. 
Procedure 
The ash obtained in (A) was boiled for 5min with 25mL of 2M hydrochloric 
acid. The insoluble matter was collected in a tared sintered glass crucible. The residue 
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was washed with hot water, ignited to constant weight, cooled in desiccators and 
weighed. The percentage of acid insoluble ash with reference to the air dried drug was 
calculated. The values were determined in triplicate. The results are presented in Table 
2 
(C) Water soluble ash:  
            It is a measurement of detection of water soluble impurities in dry or raw 
material of plant. 
          The ash obtained in (A) was boiled with 25mL of distilled water. The insoluble 
matter was collected in a Gooch crucible, washed with hot water ignited to a constant 
weight and cooled in a desiccator and weighed. The weight of the insoluble matter was 
subtracted from the weight of the total ash. The difference gave the weight of the water 
soluble ash. It was calculated with reference to the air-dried powder. The values were 
determined in triplicate. The results were represented in Table 2. 
 LOSS ON DRYING 
        Loss on drying is defined as the amount of water and volatile matters in a sample 
when the sample is dried under specified conditions. 
Procedure 
        The powdered crude drug (2g) was accurately weighed in a tarred dish and dried 
in an oven at 100˚-105 ̊C. It was cooled in a desiccator and again weighed. The loss on 
drying was calculated with reference to the amount of the dried powder taken and the 
experiment was repeated thrice. The results obtained are presented in Table.2. 
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DETERMINATION OF EXTRACTIVE VALUES 
Procedure 
(1)  Petroleum ether soluble extractive value  
  A quantity of 5g of the air dried drug coarsely powdered was macerated in 
100ml of petroleum ether in a closed flask for 24h, shaking frequently during 6h and 
allowed to stand for 18h, filtered rapidly taking precautions against loss of solvent. 
25mL of the filtrate was evaporated to dryness in a tared flat bottomed shallow dish 
and dried at 105˚C, to constant weight. The percentage of the petroleum ether soluble 
extractive with reference to the air dried drug was calculated. The results are tabulated 
in Table 2.              
(2) Ethanol and 70% ethanol soluble extractive: 
  A quantity of 5g of the air dried drug coarsely powdered was macerated in 
100mL of ethanol in a closed flask for 24h, shaking frequently during 6h and allowed 
to stand for 18h, filtered rapidly taking precautions against loss of solvent. 25mL of 
the filtrate was evaporated to dryness in a tared flat bottomed shallow dish and dried at 
105˚C, to constant weight. The percentage of alcohol soluble extractive with reference 
to the air dried drug was calculated and presented in Table 2. 
(3) Water-Soluble Extractive: 
A quantity of 5g of the air dried drug coarsely powdered was macerated in 
100mL of chloroform water in a closed flask for 24h, shaking frequently during 6h and 
allowed to stand for 18h, filtered rapidly taking precautions against loss of solvent. 
25mL of the filtrate was evaporated to dryness in a tared flat bottomed shallow dish 
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and dried at 105˚C, to constant weight. The percentage of water soluble extractive with 
reference to the air dried drug was calculated and presented in Table 2. 
(4) Ether soluble extractive: 
The above mentioned procedure for the determination of petroleum ether 
soluble extractive was followed for the determination of ether soluble extractive also 
The percentage of ether soluble extractive with reference to the air dried drug was 
calculated and presented in Table 2. 
(5) Chloroform, acetone, methanol and benzene soluble extractives: 
The procedure followed for the determination of alcohol soluble extractive 
value was adopted for the determination of chloroform soluble extractive, acetone 
soluble extractive, methanol soluble extractive and benzene soluble extractive. Instead 
of alcohol, respective solvents were used for the determination of their extractive 
values. The percentage of chloroform, acetone, methanol and benzene soluble 
extractives were calculated and presented in Table 2. 
RESULTS AND DISCUSSION 
            The results obtained for the various physical parameters like total ash, acid 
insoluble ash, water soluble ash, loss on drying and the extractive values are presented 
in Table 2. It can be seen that the acid insoluble ash was found to be 0.70±0.36 which 
indicated that very little sand and other insoluble material were present. The water 
soluble ash was found to be 5.27 ± 0.21 which indicated that inorganic mineral like 
sodium; calcium salts etc. were present in the plant material. The loss on drying was 
found to be 9.44 ± 0.27. This indicates the amount of the moisture that is generally 
present in the raw material.  
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Table 2: Analytical parameters of Justicia glauca 
S. No Parameters* 
Values* 
expressed as 
% 
1 Ash values   
 Total ash  7.40±0.36 
 Water  soluble ash 5.27±0.21 
 Acid  insoluble ash  0.70±0.36 
2 Loss on drying 9.44±0.27 
3 Extractive  values   
 Petroleum ether extract 12.06 
 Ethyl acetate 15.95 
 Benzene 10.87 
 Chloroform 11.70 
 Acetone 13.89 
 Methanol 16.72 
 Ethanol 17.26 
 75% Ethanol 18.28 
 Aqueous 16.30 
* mean of three readings ± SEM 
 
The extractive value was found to be maximum in 70% ethanol followed by 
ethanol and then water. The determination of extractive values helps in determining a 
suitable menstrum for extraction of secondary metabolites and helps in determining if 
the material has been exhausted at a future date since these values can be used as a 
standard. 
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SECTION - E 
POWDER ANALYSIS 
Procedure 
[36, 43, 44]
 
 The whole plant powder of J. glauca was treated with various chemical 
reagents like picric acid, iodine solution, Mayer’s reagent etc. on a watch glass for the 
identification of the secondary metabolites. The color/precipitate obtained with various 
reagents are presented in Table 3.  
 The powder was taken in watch glass and was treated with various acids and 
alkalis and their color in daylight and under UV light was observed. The results are 
presented in Table 4. The fluorescence analysis of the various extracts was also 
carried out to find out whether any fluorescent compound was present in the sample. 
The results obtained are tabulated in Table 5. 
RESULTS AND DISCUSSION 
The behavior of the J. glauca powder with various chemical reagents is 
tabulated in Table 3. The powder showed the presence of phytosterols, tannins, 
proteins, flavonoids, phenolic compounds. The powder showed the absence of 
alkaloids.  
The fluorescence analysis of the powder and the extracts of J. glauca are 
presented in Tables 4 & 5.  The powder when viewed under UV light at 365nm 
appeared black and dark green at 254nm when treated with sodium hydroxide.  The 
ethanolic extract when seen in day light was green 
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Table 3: Behavior of the J .glauca powder with various chemical reagents 
Powder + Reagents Colour / Precipitate Presence of active 
principle 
Picric acid Yellow precipitate Protein present 
Conc. sulfuric acid Reddish brown color Phyto sterols present 
Lieberman Burchard reagent Reddish brown color  Phyto sterols present 
Aqueous ferric chloride Greenish black color Tannins present 
Iodine solution No blue color Absence of starch 
Mayer’s reagent Cream color Alkaloids present 
Spot test No stain  Fixed oils absent 
Sulfosalicylic acid  White precipitate Protein present 
Aq. Sodium hydroxide Yellow color Flavanoids present 
Mg – HCl Magenta color Flavanoids present 
Aq. Lead acetate White precipitate Presence of tannins 
Note :-  Colour reactions are viewed under natural light by naked eye 
Table 4:  Fluorescence analysis of powder of J .glauca 
Powder +reagent  Day light UV light  
 (254 nm) 
UV light 
 (365 nm) 
Drug powder 
 
Pale green Green  Black 
Drug powder +aqueous 
1M sodium hydroxide 
Yellowish green Dark green Black 
Drug powder + alcoholic 
1M sodium hydroxide 
Yellowish green Dark green Black 
Drug powder + iodine Brown Brownish green Black 
Drug powder + 10% 
potassium hydroxide 
Yellowish green  Dark green Brown 
Drug powder +  1M 
hydrochloric acid 
Gray Green Brown 
Drug powder + glacial 
acetic acid 
Pale green Green Brown 
Drug powder + 50% 
sulphuric acid  
Green Green Brown 
Drug powder + 50% 
nitric acid 
Brown Brownish green Brown 
Drug powder + 50% 
hydrochloric acid 
Gray Green  Brown 
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Table 5:  Fluorescence Analysis of extracts of J.glauca 
Extracts Consistency Colour in 
Day Light 
Colour under UV 
Lamp 
365nm 254nm 
Petroleum 
extract 
Semisolid Green Yellowish 
green 
green 
Ether extract Semisolid Greenish 
brown 
green Green 
Chloroform 
extract 
Semisolid Greenish 
brown  
Orange  Green  
Hexane extract Semisolid  Green Reddish 
Orange  
Green  
Ethanol extract Semisolid Green Reddish 
Orange  
Green  
Methanol 
extract 
Semisolid Green Reddish 
Orange  
Green  
Aqueous extract Semisolid Greenish  
brown 
Green  Greenish 
brown 
 
The powder analysis of the crude drug material and the extract throws light on 
the type of secondary metabolites present in the plant. They also help in identifying the 
crude material and in determining the purity of the sample. 
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CHAPTER-6 
SECTION-A 
PHYTOCHEMICAL STUDIES 
COLLECTION AND PREPARATION 
[45-49]
 
The leaves of Justicia glauca were collected in and around Madurai and 
authenticated by taxonomist. The whole plant were washed thoroughly and dried in 
shade. The shade dried whole plant were powdered and used for further studies.  
PRELIMINARY PHYTOCHEMICAL SCREENING  
 
MATERIALS AND METHODS 
1. Test for sterols 
      The powdered whole plant was first extracted with petroleum ether and 
evaporated to a residue. Then the residue was dissolved in chloroform and tested for 
sterols. 
a.  Salkowski’s Test 
 A few drops of concentrated sulphuric acid were added to the above solution, 
shaken well and set aside. The lower chloroform layer of the solution appears red in 
color indicates the presence of sterols. 
b.  Liebermann – Burchard’s Test 
 To the chloroform solution, a few drops of acetic anhydride and 1mL of conc. 
sulphuric acid were added through the sides of the test tube and set aside for a while. 
At the junction of two layers a brown ring will be formed and the upper layer turns 
green indicating the presence of sterols.  
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2. Test for terpenoids 
 A little of the powdered whole plant was extracted with chloroform and 
filtered. The filtrate was warmed gently with tin and thionylchloride. Pink color 
solution appears indicates the presence of terpenoids. 
3. Test for carbohydrates 
a.  Molisch’s Test: 
 The aqueous extract of the whole plant powdered when treated with alcoholic 
solution of α-naphthol in the presence of sulphuric acid. A purple color indicates the 
presence of carbohydrates. 
b.  Fehling’s Test: 
 The aqueous extract of the whole plant powdered was treated with Fehling’s 
solution I and II and heated on a boiling water bath for half an hour. A red precipitate 
indicates the presence of free reducing sugars. 
4. Test for Flavonoids 
a. Magnesium turning – conc. HCl test: 
A little of the powdered drug was heated with alcohol and filtered. To the test 
solution magnesium turnings and few drops of concentrated hydrochloric acid were 
added and boiled for five minutes. A red colour indicates the presence of flavonoids. 
b. Alkali Test 
           To a small quantity of test solution 10% aqueous sodium hydroxide solution 
was added.  A yellow orange color indicates the presence of flavonols.  
c. Acid Test 
               To a small quantity of test solution, few drops of concentrated sulphuric acid 
was added. A yellow orange color indicates the presence of flavonols. 
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7. Test for Proteins 
a. Millon’s Test  
A small quantity of aciduous – alcoholic extract of the powdered drug was 
heated with Millon’s reagent. A white precipitate turning red on heating indicates the 
presence of proteins.  
b. Biuret Test  
           To one portion of aciduous – alcoholic extract of the powdered drug one mL of 
10% sodium hydroxide solution was added, followed by this one drop of dilute copper 
sulphate solution was added. A violet color indicates the presence of proteins. 
8. Test for Alkaloids 
a. About 2gm of the powdered material was mixed with 1gm of calcium 
hydroxide and 5mL of water into a smooth paste and set aside for 5min. It was then 
evaporated to dryness in a porcelain dish on a water bath. To the residue 20mL of 
chloroform was added, mixed well and refluxed for half an hour on a water bath. Then 
it was filtered and the chloroform was evaporated. To the residue 5ml of dilute 
hydrochloric acid was added followed by 2mL of each of the following reagents. 
a) Mayer’s Reagent                 _       cream precipitate 
b) Dragendorff’s Reagent        _      orange brown precipitate 
c) Hager’s Reagent                  _       Yellow precipitate  
d) Wagner’s Reagent               _        Reddish brown precipitate 
9. Test for Glycosides 
a.  Borntrager’s Test 
            The whole plant powder was boiled with dilute sulphuric acid, filtered and to 
the filtrate benzene was added and shaken well. The organic layer was separated to 
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which ammonia solution was added slowly. A pink color in the ammoniacal layer                
indicates the presence of anthraquinone glycosides. 
b.  Modified Borntrager’s Test 
            About 0.1g of the powdered drug was boiled for 2min with dilute hydrochloric 
acid and few drops of ferric chloride solution, filtered while hot and cooled. The 
filtrate was then extracted with benzene and the benzene layer was separated. Equal 
volume of dilute ammonia solution was added to the benzene extract. A pink color 
indicates the presence of anthraquinone  glycosides. 
Test for Cardiac Glycosides (for deoxysugar) 
Keller Kiliani Test 
         About 1g of the powdered leaf was boiled with 10ml of 70% alcohol for 2min, 
cooled and filtered. To the filtrate 10mL of water and 5 drops of solution of lead 
subacetate were added and filtered, evaporated to dryness. The residue was dissolved 
in 3mL of glacial acetic acid. To this, 2 drops of ferric chloride solution was added. 
Then 3mL of conc. sulphuric acid was added to the sides of the test tube carefully and 
observed. A reddish brown layer indicates the presence of deoxysugars of cardiac 
glycoside 
Test for Cyanogenetic Glycosides 
          A small quantity of the powder was placed in a stoppered conical flask with just 
sufficient water to cover it. A sodium picrate paper strip was inserted through the 
stopper so that it was suspended in the flask and it was set aside for 2h in a warm 
place. A brick red color was produced on the paper indicating the absence of 
cyanogenetic glycosides.  
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10. Test for saponins 
           About 0.5g of the powdered drug was boiled gently for 2min with 20mL of 
water and filtered while hot and allowed to cool. 5mL of the filtrate was then diluted 
with water and shaken vigorously.  A frothing  indicates the presence of saponins. 
11. Test for Tannins  
          A small quantity of the powdered drug was extracted with water. To the aqueous 
extract few drops of ferric chloride solution was added. A bluish black color indicates 
the presence of tannins. 
12. Test for the presence of Volatile oil 
A weighed quantity of 250gm of fresh leaves was subjected to hydrodistillation 
using volatile oil estimation apparatus (BP 1980). A flavoured oil collected indicates 
the presence of volatile oil. 
The above preliminary phytochemical reactions were carried out the powdered 
material of Justicia glauca and on the various extracts of the crude powder. The results 
obtained are tabulated in Tables 6 & 7. 
RESULTS AND DISCUSSION 
 The results obtained for the preliminary phytochemical screening of the 
powder indicated the presence of phytosterols, proteins, carbohydrates, phenolic 
compounds, alkaloids, flavonoids and cardiac glycosides. It showed absence for 
antraquinone glycosides, terpenoids and volatile oil. 
 The aqueous extract of the J. glauca showed the presence of flavonoids, 
phenolic compounds, alkaloids, proteins and carbohydrates. The ethanolic extract of 
J.glauca shows the presence of flavonoids, phenolic compounds, alkaloids, protein 
and carbohydrates. The methanolic extract of J.glauca shows the presence of 
flavonoids, phenolic compounds, alkaloids, proteins and carbohydrates. 
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Table 6:  Preliminary phytochemical screening for the powder of Justicia glauca 
 
S. No                                TEST RESULTS 
1. TEST FOR STEROLS  
 a. Salkowski’s test - 
 b. Libermann- burchard’s test - 
2. TEST FOR CARBOHYDRATES  
 a. Molisch’s test + 
 b. Fehling’s test + 
 c. Benedict’s test + 
3. TEST FOR PROTEINS  
 a. Millon’s test + 
 b. Biuret test + 
4. TEST FOR ALKALOIDS  
 a. Mayer’s reagent + 
 b. Dragendroff’s reagent + 
 c. Hager’s reagent + 
 d. Wagner’s reagent + 
5. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides  
     i) Borntrager’s test - 
     ii) Modified Borntrager’s test - 
 b. Cardiac glycosides  
     i) Keller Killiani test  + 
 c. Cyanogenetic glycosides - 
6. TEST FOR SAPONINS - 
7. TEST FOR TANNINS   
 Fecl3 test  + 
8. TEST FOR FLAVONOIDS  
 a. Shinoda test + 
 b. Alkali test + 
 c. Acid test + 
9. TEST FOR TERPENOIDS - 
10. TEST FOR VOLATILE OILS - 
              (+) indicates positive reaction            (-) indicates negative reaction   
The petroleum ether extract of J. glauca shows the presence of sterols and 
cardiac glycosides. The chloroform extract of J. glauca shows the presence of sterols 
and cardiac glycosides. The acetone extract of J. glauca shows the presence of cardiac 
glycosides, tannins and flavonoids. 
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Table 7: Preliminary phytochemical screening of 
various extracts of Justicia Glauca 
 
(+) indicates positive reaction                 (-) indicates negative reaction    
 
Tests Pet. 
ether 
Extrac
t 
Ether 
Extrac
t 
Benze
ne 
Extrac
t 
Chlor
o 
form 
Extra
ct 
Aceto
ne 
Extra
ct 
Methan
ol 
Extract 
Etha
nol 
Extra
ct 
Ethan
ol 
extrac
t 
(70%) 
Aque
ous 
 
extra
ct 
I  Test for sterols   
Salkowski’s 
test 
+ - -   + - - - - - 
Libermann- 
Burchard’s test 
+ - -   + - - - - - 
II. Test for Carbohydrates 
Molisch’s test - - - - - + + + + 
Fehling’s test - - - - - + + + + 
Benedict’s test - - - - - + + + + 
III.Test for Proteins 
Millon’s test - - - - - + + + + 
 Biuret test -  - - - + + + + 
IV.Test for Alkaloids 
Mayer’s 
reagent 
- - - - - + + + + 
Dragendroff’s 
reagent 
- - - - - + + + + 
 Hager’s 
reagent 
- - - - - + + + + 
Wagner’s 
reagent 
- - - - - + + + + 
V.Test for Glycosides 
Anthraquinone 
glycosides 
- - - + - - - - - 
    i) 
Borntrager’s 
test 
- - - + - - - - - 
    ii) Modified 
Borntrager’s 
test 
- - - + - - - - - 
 Cardiac 
glycosides 
         
    i)Keller 
Killiani test  
+ + + + + + + + + 
Cyanogenetic 
glycosides 
- - - - - - - - - 
VI.Test for 
Saponins 
- - - - - - - - - 
VII.Test for Tannins 
Fecl3 test  - - - - + + + + + 
VIII.Test for Flavonoids 
Shinoda test - - - - + + + + + 
Alkali test - - - - - + + + + 
Acid test - - - - - + + + + 
IX.Test for 
Terpenoid 
- - - - - - - - - 
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SECTION-B 
TOTAL PHENOL, TOTAL FLAVANOID AND VITAMIN C 
DETERMINATION 
[50- 54]
 
 
PREPARATION OF EXTRACT 
About 1kg of the dried powdered leaf of Justicia glauca was defatted with 
2.5L of petroleum ether (60-80
°
C) by maceration. The solvent was then removed by 
filtration and the marc is dried.  To the dried marc 2.5L of 70% ethanol was added and 
the extraction was performed by triple maceration.  It was then filtered and the 
combined filtrate was evaporated to a cohesive mars using rota vapour. 
TOTAL PHENOL DETERMINATION 
Principle 
 The total phenolic content of the various extracts of J. glauca were determined 
by Folin Ciocalteu reagent method. All the phenolic compounds are oxidised by the 
Folin-Ciocalteu Reagent, which is reduced during oxidation of the phenolic 
substances, into a mixture of blue molybdenum and tungsten oxides. The blue colour 
produced has a maximum absorption at about 750-760nm. The absorption is 
proportional to the quantity of oxidised phenolic compounds. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents   
a) Folin Ciocalteu Reagent (1N) 
 Commercially available Folin Ciocalteu Reagent (2N) was diluted with   an 
equal volume of distilled water. The resultant solution was kept in a brown   color 
bottle and stored in refrigerator at 4ºC. 
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b) Sodium carbonate solution (10%) 
c) Standard gallic acid solution. 
Procedure 
           Gallic acid was accurately weighed and diluted in water to concentration of 
1mg/mL. This solution was suitably diluted to get concentrations ranging from 2, 4, 6, 
8 and 10µg/mL.  0.5mL of Folin Ciocalteu reagent was added and allowed to stand for 
15min. Then 1mL of 10% sodium carbonate solution was added. Finally the mixtures 
were mixed with distilled water and made upto10mL, allowed to stand for 30min at 
room temperature and total phenols were determined spectrophotometrically at 760nm 
using the reagent as blank. 
The ethanolic extract of J. glauca was weighed and diluted to get a solution of 
1mg/mL. Different concentrations of the solution were taken in separate test tubes. 
0.5mL of Folin Ciocalteu reagent was added and allowed to stand for 15min. Then 
1mL of 10% sodium carbonate solution was added. Finally the mixtures were mixed 
with distilled water and made upto 10mL, allowed to stand for 30min at room 
temperature and total phenols were determined spectrophotometrically at 760nm using 
the reagent as blank. 
             A calibration curve was generated by plotting concentration of gallic acid 
versus absorbance (Fig. 16). A linear regression equation was determined. The total 
phenol content was calculated using the linear regression equation and expressed in 
terms mg of gallic acid equivalent per gm of extract (mg GAE/g). The results obtained 
are presented in Table 8. 
 
 
 
PHYTOCHEMICAL STUDIES 
 
Department of Pharmacognosy, MMC  
 44 
 
TOTAL FLAVANOIDS CONTENT  
Principle 
The aluminum chloride colorimetric technique was used for estimation of total 
flavonoid estimation. Aluminum ions form stable complexes with C4 keto group and 
either to C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It also 
forms acid labile complexes with ortho hydroxyl groups in the A or B rings of 
flavonoids. These complexes showed a strong absorption at 415nm which is used for 
the estimation of flavonoids.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
10S% aluminum chloride 
1M potassium acetate 
Procedure 
An aliquot quantity of quercetin was dissolved in ethanol to get a stock 
solution of 1mg/mL. Further dilutions were made to get concentrations ranging from 
20-100µg/mL. 1ml of the above standard solutions were taken in different volumetric 
flasks, 0.1mL of aluminum chloride solution, 0.1mL of potassium acetate solution and 
2.8mL of ethanol were added and the final volume was then made up to 5mL with 
distilled water. After 20min the absorbance was measured at 415nm. A sample without 
aluminium chloride was used as a blank. From the absorbance obtained, a calibration 
curve was constructed by plotting concentration versus absorbance of quercetin 
(Fig.17). 1mL of methanolic extract at concentrations 40µg/mL and 80µg/mL were 
taken and the reaction was carried out as above and the absorbance was measured at 
415nm after 20min and the readings were tabulated in Table 9. The amount of 
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flavonoids present can be determined by linear regression analysis. The total flavonoid 
content was expressed as mg querecetin equivalents /g of extract. 
ESTIMATION OF VITAMIN C 
[55]
 
Principle 
            Ascobic acid was estimated according to the method Sarojini et al. The keto 
group of ascorbic acid undergoes a condensation reaction with 2,4 dinitro phenyl 
hydrazine to form a hydrazone which is orange yellow and has a maximum  
absorbance of about 520nm. 
Instrument 
            Shimadzu UV Visible spectrophotometer, Model 1800 
Reagent 
            Dinitro phenyl hydrazine 
            85% sulphuric acid 
Preparation of test solution 
          1gm cut pieces of fresh plant material was soaked in 70% ethanol for 24h. The 
plant extract was filtered and used. 
Procedure 
          An aliquot quantity of ascorbic acid was weighed and dissolved in water to get 
stock solution of 1mg/mL. Further dilutions were made to get the concentrations 
ranging from 5-25µg/mL. To 1mL of sample, 0.5mL of dinitro phenyl hydrazine 
solution was added and incubated for 3h at 37°C. After 3h, 2.5mL of 85% sulphuric 
acid was added and the absorbance was measured after 30min at 520nm. A calibration 
curve was constructed by plotting concentration versus absorbance of ascorbic acid 
(Fig. 18). The procedure was repeated for the plant extract as above and the 
absorbance was measured at 520nm after 3h and the reading were tabulated in table 
PHYTOCHEMICAL STUDIES 
 
Department of Pharmacognosy, MMC  
 46 
 
10. The amount of the vitamin C present can be determined by linear regression 
analysis. The vitamin C content was expressed as mg/g of extract. The results obtained 
are presented in Table 10. 
RESULTS AND DISCUSSION 
Total phenol estimation 
 The results for the total phenol estimation of ethanolic extract of Justicia glauca 
are tabulated in Table 8. 
           Table 8: Total phenolic content in ethanolic extract of Justicia glauca  
in terms of gallic acid equivalents 
 
S. 
No. 
Conc. 
of 
gallic 
acid in 
µg/mL 
Absorbance 
at 760nm 
Conc. of 
ethanolic 
extract 
in µg/mL 
Absorbance 
at 760nm* 
Amount of 
total 
phenolic 
content in 
terms 
mgGAE/g of 
extract* 
1 2 0.229 ± 0.010 50 0.306±0.02 53.4±0.02 
2 4 0.452 ± 0.006 100 0.724±0.03 62.8±0.06 
3 6 0.695 ± 0.005    
4 8 0.918 ± 0.031    
5 10 1.162 ± 0.028  Average 58.6±0.03 
* mean of three readings ±SEM 
Fig. 16:  Calibration curve of Gallic acid 
 
The linear regression equation was found to be y= 092x - 0.028 while the 
correlation was found to be 0.994. The amount of phenol content present in the extract 
y = 0.092x - 0.028
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in terms mg GAE/g of extract was found to be 58.6±0.03 by using the above linear 
regression equation. 
Total flavonoid estimation 
 The results for the total flavonoid estimation of ethanolic extract of Justicia 
glauca are tabulated in Table 9. 
Table 9: Total flavonoid content per gram of extract in terms of quercetin  
                                         by aluminium chloride method 
 
S. 
No. 
Conc. of 
quercetin 
in µg/mL 
Absorbance 
at 415nm 
Conc. of 
methanolic 
extract in 
µg/mL 
Absorbance 
at 415nm 
Amt of total 
flavonoid 
content in terms 
mg quercetin 
equivalent/ g of 
extract 
1 20 0.589 ± 0.01 100 0.048±0.03 29.07±0.06 
2 40 1.151 ± 0.04 200 0.128±0.01 27.02±0.04 
3 60 1.710 ± 0.09    
4 80 2.390 ± 0.03    
5 100 3.112 ± 0.03  Average 29.35±0.03 
                                   *mean of three readings ± SEM 
Fig. 17: Calibration curve of quercetin 
 
The linear regression equation was found to be y=0.0307x-0.0432 while the 
correlation was found to be 0.9974. The amount of flavonoid content present in the 
Calibration curve of quercetin
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y = 0.002x + 0.012
R² = 0.998
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(Absorbance)
extract in terms mg quercetin equivalent/g of extract was found to be 29.35±0.03by 
using the above linear regression equation. 
Estimation of vitamin C 
The results for vitamin C content of ethanolic extract of Justicia glauca are 
presented in Table 10.  
Table 10: Estimation of Vitamin C in Justicia glauca 
  
         *mean of three readings ± SEM 
                                    
Fig. 18: Calibration curve of ascorbic acid 
 
 
 
 
 
 
  
 
 
 The linear regression equation was found to be y = 0.002x + 0.012 and a 
correlation coefficient of 0.998. The amount of vitamin C content present in the 
S. 
No. 
Conc. of 
ascorbic 
acid in 
µg/mL 
Absorbance 
at 520nm 
Conc. of 
methanolic 
extract in 
µg/mL 
Absorbance at 
520nm 
Amt of 
vitamin C 
present / g of 
extract 
1 40 0.135 ± 0.000 40 0.028±0.02 8.02±0.02 
2 80 0.265 ± 0.015 80 0.032±0.01 10.08±0.01 
3 120 0.346 ± 0.010 120 0.045±0.03 14.52±0.07 
4 160 0.468 ± 0.011 160 0.055±0.07 20.78±0.02 
5 200 0.525 ± 0.010 200 0.069±0.02 26.32±0.03 
    Average 15.94± 0.01 
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ethanolic extract of Justicia glauca was found to be 15.94± 0.01mg/gm of fresh 
material by using the above linear regression equation.       
 The estimation of secondary metabolites in terms standard marker compounds 
helps in understanding the type of secondary metabolites present. The results obtained 
show that the ethanolic extract of Justicia glauca was found to possess 58.6±0.03mg/g 
GAE of phenolic compounds and 29.35±0.03mg/g quercetin equivalent of flavonoids 
and 15.94± 0.01mg/gm of ascorbic acid. The high amount of phenolic and flavonoids 
may be attributed to the pharmacological activity of the plant   
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SECTION-C 
CHROMATOGRAPHY - TLC AND HPTLC STUDIES 
[56-59] 
Plant extracts contains complex mixture of different components and it is 
necessary to separate them before quantification. Chromatography comprises a group 
of techniques for isolation of molecular mixtures that depends on the differential 
affinities of the solutes between two immiscible phases. One of the phases is a fixed 
bed of large surface area known as stationary phase, while the other is fluid, which 
moves through or over the surface of the fixed phase known as mobile phase. The 
principle involved in chromatographic techniques is adsorption and partition.  
         The different methods of chromatography include paper chromatography (PC), 
thin layer chromatography (TLC), column chromatography (CC), gas chromatography 
(GC), high performance liquid chromatography (HPLC) and high performance thin 
layer chromatography (HPTLC). 
The phytochemical evaluation of ethanolic extract of Justicia glauca was 
carried out using TLC and HPTLC studies. 
DEVELOPMENT OF CHROMATOGRAMS 
Materials and method 
The extracts were dissolved in ethanol and the spot was applied on the TLC 
plates using capillary tube. 
The plates were developed in the chromatographic tank containing the solvent 
systems.  Various solvent systems were tried for better results.  The TLC plates were 
allowed to develop upto 2/3
rd
 of the plate length and dried.  The TLC plates were 
examined visually or under UV light. 
 Stationary phase -  Silicagel G 
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 Mobile phase   -  Toluene: Ethylacetate: Acetic aci (7:3:0.1) 
 Detecting agent           -  Visual & UV light  
The Rf value of the spots obtained were calculated using the formula, 
   Distance travelled by solute 
 Rf  value =    ------------------------------------ 
    Distance travelled by solvent 
 
The results obtained for the TLC analysis is presented in Table 11. 
HPTLC EVALUATAION OF ETHANOLIC EXTRACT OF Justicia glauca 
Instrument used : CAMAG make HPTLC. 
Software  : winCATS 1.4.3 
Sample Applicator : Linomat 5. 
Detection            : @254nm in Densitometry TLC Scanner 3 
STD Preparation : 10 mg of STD is dissolved in 1ml Ethanol 
Sample preparation : The sample was prepared in Ethanol 50mg / 1 ml 
Stationary Phase : HPTLC plates silica gel 60 F 254. 
Mobile Phase  : Toluene: Ethyl acetate: Acetic Acid (7:3:0.1) 
Sample Applied : 2µl sample is applied as 8mm band. 
 The results obtained are presented in Table 12 and the TLC visualization and 
3D peak display are presented in Figs. 19 to 21.  
RESULTS AND DISCUSSION 
The results obtained for the TLC analysis with the mobile phase is presented in 
Table 11. The TLC plates when examined under UV light at 365nm showed the 
presence of  5 spots which may be attributed to the presence of different active 
principles in ethanolic extract of Justicia glacua. The spots showed fluorescence when 
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viewed under UV light at 365nm. The active principle at Rf value 0.7 may be 
responsible for the antioxidant activity due to its phenolic nature. 
Table 11: Phytochemical evaluation of ethanolic exract by TLC studies. 
 
High Performance Thin Layer Chromatography 
The visualization of the TLC plate of ethanolic extract of J. glauca at 254nm, 
366nm and white light is presented in Fig. 19. The photo of plate at 254nm showed the 
presence of 13 spots while at 366nm showed the presence 9 spots and one spot was 
seen when viewed under white light.                               
Fig. 19:  Visualization at 254nm, 366nm & white light 
@254nm    @366nm             Whitelight 
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Fig. 21: Peak display of ethanolic extract of J. glauca at 254nm and 366nm 
                      @254nm      @366nm
                      
White light 
 
Table 12: Rf values and area under the curve  
for each peak at 254, 366nm and white light 
 
S. No 
@254nm @366nm White light 
Rf 
Value 
AREA 
(AU) 
Rf 
Value 
AREA 
(AU) 
Rf 
Value 
AREA 
(AU) 
1 0.08 481.4 0.13 149.3 0.13 121.0 
2 0.11 512.8 0.16 517.9   
3 0.16 3869.2 0.35 1409.6   
4 0.22 783.2 0.39 550.7   
5 0.25 426.2 0.44 742.8   
6 0.33 502.9 0.49 296.5   
7 0.41 1081.8 0.68 759.4   
8 0.44 5234.0 0.74 294.5   
9 0.52 574.4 0.78 625.6   
10 0.57 178.5     
11 0.74 215.1     
12 0.78 224.8     
13 0.85 8812.2     
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The HPTLC finger print profile of the ethanolic crude plant extract of J. glauca 
showed spots with different Rf values indicating the plant contains many medicinally 
active compounds which may be responsible for its therapeutic activity. The peak 
display and finger print profile can be utilized for the quality control for different test 
samples of J. glauca by comparing different chromatograms with the standard 
obtained in the present study. No two finger prints are same, similarly no two finger 
print profiles of the extract of different plants are same and hence useful in the identity 
of J. glauca in future.     
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CHAPTER - 7   
PHARMACOLOGICAL SCREENING   
SECTION A 
INVITRO ANTIOXIDANT ACTIVITY  
              An antioxidant is a molecule capable of inhibiting the oxidation of other 
molecules. Oxidation is a chemical reaction that transfers electrons or hydrogen from a 
substance to an oxidizing agent. Oxidation reactions can produce free radicals. In turn, 
these radicals can start chain reactions. When the chain reaction occurs in a cell, it can 
cause damage or death to the cell.  
              Antioxidants terminate these chain reactions by removing free radical 
intermediates, and inhibit other oxidation reactions. They do this by being oxidized 
themselves, so antioxidants are often reducing agents such as thiols, ascorbic acid, or 
polyphenols.  
             The antioxidants scavenge the free radical generated, due to oxidative stress 
and exhibit a protective effect against many diseases like cancer, cardiovascular 
disease, diabetes and ageing. Generation of ROS overtakes the antioxidants defence of 
the cells, the free radicals start attacking the cell proteins, lipids and carbohydrates and 
this leads to development of degenerative diseases .Hence the rationale for the use of 
antioxidant is well established in prevention and treatment of diseases where oxidative 
stress plays a major aetiopathological role.  
              Antioxidant may protect the body against ROS toxicity either by preventing 
the formation of ROS by bringing interruption in ROS attack by scavenging the 
reactive metabolites or by converting them to less reactive molecules . The antioxidant 
capacity gives information about the duration while the activity describes the starting 
dynamics of antioxidant action. Therefore the uses of antioxidants, both natural and 
PHARMACOLOGICAL SCREENING 
 
Department of Pharmacognosy, MMC  
 57 
 
synthetic are gaining wide importance in prevention of diseases. Some of the in-vitro 
models for the evaluation of antioxidant activity are listed below. 
 DPPH method 
 Superoxide radical scavenging activity 
 Hydroxyl radical scavenging activity 
 Nitric oxide radical inhibition assay 
 Reducing power method 
 Phosphomolybdenum method 
 Peroxy nitrile radical scavenging activity 
 Xanthine oxidase method 
 Ferric reducing ability of Plasma 
 Thiobarbituric acid assay etc. 
Method 1 : Diphenyl picryl hydrazyl (DPPH) method
[60-64]
  
DPPH is a well-known radical and a trap ("scavenger") for other radicals. 
Therefore, rate reduction of a chemical reaction upon addition of DPPH is used as an 
indicator of the radical nature of that reaction. Because of a strong absorption band 
centered at about 520 nm, the DPPH radical has a deep violet color in solution, and it 
becomes colorless or pale yellow when neutralized. This property allows visual 
monitoring of the reaction, and the number of initial radicals can be counted from the 
change in the optical absorption at 520 nm or in the EPR signal of the DPPH.(ref.2) 
DPPH
.
  + AH →  DPPH-H  +  A
.
 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
0.1mM diphenyl picryl hydrazyl in ethanol 
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Procedure 
To the 1mL of test samples of different concentrations, 4mL of DPPH was 
added. Control without test compound was prepared in an identical manner. Blank was 
prepared in the similar way, where DPPH was replaced by ethanol. The reaction was 
allowed to be completed in the dark for about 30min. Then the absorbance of test 
mixtures was read at 517nm. The percentage inhibition was calculated and expressed 
as percent scavenging of DPPH radical. Vitamin C was used as standard.  The 
percentage scavenging was calculated using the formula 
%inhibition = [(Control-Test)/Control] x 100 
A graph was constructed using concentration versus percentage inhibition (Fig. 22). 
The concentration of the sample required for 50% reduction in absorbance (IC50) was 
calculated using linear regression analysis. The results obtained are presented in Table 
13. 
Method 2: Nitric oxide scavenging activity assay 
[65] 
Principle  
           Nitric oxide scavenging activity was determined according to the method 
reported by Green et al., 1982 [78]. Sodium nitropruside in aqueous solution at 
physiological pH spontaneously generates nitric oxide, which interact with oxygen to 
produce nitrite ions. These nitrite ions can be determined by Griess Illosvoy reaction.  
         The nitrite ions produced diazotizes sulphanilamide and the diazonium salt 
thus obtained reacts with NN naphthyl ethylene diamine dihydrochloride to give a 
pink colour chromophore which has a maximum absorption at 546nm. 
         Nitric oxide (NO), being a potent pleiotropic mediator in physiological process 
and a diffusible free radical in pathological conditions, reacts with superoxide anion 
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and form a potentially cytotoxic molecule, the peroxinitrite (ONOO-).Its protonated 
form , peroxinitrous acid (ONOOH)  is a very strong oxidant (ref.6) 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
10mM sodium nitroprusside 
Phosphate buffered saline pH 7.4 
2% sulphanilamide in ortho phosphoric acid 
0.1%  naphthyl ethylene diamine dihydrochloride  
Procedure  
To 1mL of sodium nitroprusside, 2.5mL phosphate buffered saline pH 7.4 was 
added.  1mL of extracts at various concentrations were added to the above solution and 
the mixture was incubated at 25
o
C for 30min. To 1.5mL of the incubated mixture add 
1mL of sulphanilamide in phosphoric acid and 0.5mL of naphthyl ethylene diamine 
dihydrochloride. The absorbance was measured at 546nm. Ascorbic acid was used as a 
standard. The percentage inhibition of nitric oxide radical generated was calculated 
using the following formula:  
% inhibition = [(Control-Test)/Control] x 100.  
The IC50 was calculated using linear regression analysis. The results wewe presented 
in Table 14 and Fig. 23. 
Method 3: Scavenging of hydrogen peroxide activity 
[61, 62, 66]
 
Principle 
Hydrogen peroxide is a weak oxidizing agent and can inactivate a few enzymes 
directly,usually by oxidation of essential thiol(-SH) groups. Hydrogen peroxide can 
propably react with Fe+2 and possibly Cu+2 to form hydroxyl radical and this may be 
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the orgin of many of its toxic effects.It is therefore biologically advantages for cells to 
control the amount of hydrogen peroxide that is allowed to accumulate. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
 Hydrogen peroxide 
Procedure 
A solution of hydrogen peroxide (40mM) was prepared in phosphate buffer 
(pH 7.4). the concentration of hydrogen peroxide was determined by absorption at 
230nm using a spectrophotometer. Extracts (0.1-1mg/mL) in distilled water were 
added to hydrogen peroxide solution. (0.6 ml 4mM).The absorbance of hydrogen 
peroxide at 230nm was determined after ten minutes against a blank solution 
containing phosphate buffer without hydrogen peroxide. The standard vitamin C was 
treated in a similar manner. The results are tabulated in Table 15 and Fig. 24. 
 
RESULTS AND DISCUSSION  
Method 1: Diphenyl picryl hydrazyl (DPPH) method       
 The results obtained for radical scavenging activity against DPPH is presented 
in Table 13. From the table, it can been seen that the ethanolic extract of J. glauca 
showed a percentage inhibition of 92.36± 0.42 while ascorbic acid showed  a 
percentage inhibition of 96.38± 0.36 at a concentration of 200µg/mL.  The IC50 value 
calculated using the linear regression analysis was found to be 19.69 and 78.46µg/mL 
for ethanolic extract and ascorbic acid respectively (Fig.22). The extract possessed a 
good radical scavenging capacity. 
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Table 13: Percentage inhibition of ethanolic extract of 
J. glauca and standard ascorbic acid against DPPH at 517nm 
 
S. No. Conc. in 
µg/mL 
Percentage 
inhibition by 
ascorbic acid 
Percentage 
inhibition by J. 
glauca 
1 40 91.06± 0.15 30.33± 0.32 
2 80 93.27± 0.26 62.36± 0.28 
3 120 94.77± 0.23 86.28± 0.29 
4 160 95.58± 0.46 90.17± 0.38 
5 200 96.38± 0.36 92.36± 0.42 
 IC50 19.69µg/mL 78.46µg/mL 
*mean of three readings ± SEM 
 
Fig. 22: Free radical scavenging of 70% ethanolic extract  
of J. glauca and ascorbic acid against DPPH 
        
 
 Method 2: Nitric oxide scavenging activity 
 
The results obtained for the free radical scavenging activity against nitric oxide 
radical are presented in Table 14. From the table, it can been seen that the ethanolic 
extract of J. glauca showed a percentage inhibition of 77.45 ± 0.05 while ascorbic acid 
showed a percentage inhibition of 82.94±0.27 at a concentration of 500µg/mL.  The 
IC50 value calculated using the linear regression analysis was found to be 155.26 and 
87.61 µg/mL (Fig. 23) for ethanolic extract and ascorbic acid respectively 
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Table 14: Percentage inhibition of ethanolic 
extract of Justicia glauca against nitric oxide at 546nm 
 
S. No. Conc. in 
µg/mL 
Percentage 
inhibition by  
ascorbic acid 
Percentage 
inhibition by 
extract 
1 31.25 57.58±0.56 53.44 ± 0.46 
2 62.5 59.47±0.24 56.06 ± 0.22 
4 125 72.38±0.37 57.83 ± 0.32 
5 250 75.04±0.45 59.08 ± 0.38 
6 500 82.94±0.27 77.45 ± 0.05 
 IC50 87.61µg/mL 155.26µg/mL 
 
*mean of three readings ± SEM 
 
          Fig. 23: Nitric oxide radical scavenging by 70% ethanolic extract of  
                                               J. glauca and ascorbic acid 
 
 
.  
Method 3: Determination of scavenging activity against hydrogen peroxide  
The results obtained for the scavenging activity against hydrogen peroxide are 
presented in Table 15. From the table, it can been seen that the ethanolic extract of J. 
glauca showed a percentage inhibition of 78.12 ±0.36 while ascorbic acid showed a 
percentage inhibition of 76.29±0.85 at a concentration of 200µg/mL. The IC50 value 
calculated using the linear regression analysis was found to be 192.16 and 119.55 
µg/mL (Fig. 24) for ethanolic extract and ascorbic acid respectively.  
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Table 15: Percentage inhibition of hydrogen peroxide 
 by ethanolic extract of Justicia glauca 
 
S. No. Conc. in 
µg/mL 
Percentage inhibition 
Ethanolic 
extract of J. 
glauca 
Ascorbic acid 
1 40 38.56±0.12 12.92±0.30 
2 80 47.21± 0.25 17.40±0.53 
3 120 59.76± 0.32 38.12±0.96 
4 160 65.42± 0.23 64.37± 0.40 
5 200 78.12 ±0.36 76.29±0.85 
 IC50  192.16µg/mL 119.55 µg/mL 
*mean of three readings ± SEM 
 
Fig. 24:  Scavenging activity by hydrogen peroxide method 
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SECTION - B 
CARDIOPROTECTIVE EFFECT OF LEAF EXTRACT OF JUSTICIA 
GLAUCA ON DOXORUBICIN INDUCED CARDIOTOXICITY IN RATS  
 [67-76]
 
 
Doxorubicin is an effective and broad spectrum antineoplastic agent used in the 
treatment of a variety of haematologic and solid malignancies, such as leukaemias, 
bladder, lung and breast cancers, Hodgkin’s and non-hodgkin’s lymphomas. Its 
clinical uses are often limited by its adverse effect namely cardiotoxicity. An initial 
acute effect includes hypotension and transient ECG abnormalities reported upto 41% 
of patients. The chronic effect may occur several weeks or months after cumulative 
doxorubicin administration and occurrence is dose dependent cardiomyopathy which 
accounts for as high as 50% mortality within two years after diagnosis. The high level 
of doxorubicin could damage membranes, proteins eg. enzymes, structural and 
receptors and DNA that may leads to cardiac dysfunction and apoptosis .  
Administration of the doxorubicin at 15mg/kg body weight of albino rats leads to 
cardiomyopathy and heart failure. 
MATERIALS AND METHODS 
Animals 
Male albino rats (150-200g) were procured from the Central Animal House, 
Institute of Pharmacology, Madurai Medical College. The animals were housed under 
standard conditions of temperature (25
o 
± 2
o
C) and photoperiod of 12h dark/light cycle 
with food and water ad libitum. The Institutional Animal Ethical Committee clearance 
was obtained and the experimental study was conducted according to the protocol 
approved by them. 
 
Chemicals and reagents 
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 CK-MB Diagnostic Kit 
 LDH Diagnostic Kit 
 Tris HCl Buffer 
 Thiobarbituric acid (TBARS) 
 DTNB Reagent 
 Doxorubicin - reconstituted with sterile water for injection administered 
intraperitoneally to rats at a dose of 15mg/kg to induce cardiotoxicity. 
Experimental Protocol 
The animals were divided into 4 groups and each group consists of six animals 
(n=6).  Group I and II animals were administered 1% CMC alone while group III and 
IV animals were administered with ethanolic extract of Justicia glauca - (suspension 
in 1% CMC) at 100mg/kg and 200mg/kg doses respectively.   On the fifth day,  group 
III, IV animals were administered extracts an hour prior to the administration of 
doxorubicin  
GROUP  TREATMENT 
I 1% CMC in distilled water for five consecutive days 
orally 
           II                              Single dose for doxorubicin at 15mg/kg IP was     
administered on
 
fifth day alone. 
III                                 EJG at 100mg/kg po was administered for 5 consecutive  
days and doxorubicin 15mg/kg IP on the fifth day alone.  
IV   EJG at 200mg/kg po was administered for 5 consecutive                                 
                                     days and doxorubicin 15mg/kg IP on the fifth day alone. 
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   After 24 hours of doxorubicin administration blood samples were collected. All 
the animals were sacrificed as per the CPCSEA guidelines. The heart was isolated and 
used for histopathological and in vivo antioxidant studies. 
Parameters evaluated 
 Serum parameters 
CK-MB and LDH 
 Estimation of in vivo antioxidants in cardiac tissue homogenate                             
TBARS,  GSH and Total protein. 
 Histopathological studies 
Estimation of serum parameters 
The marker enzymes CK-MB and LDH were assayed in serum using Standard 
Kits. The results obtained are presented in the Table 16 and the graphical 
representation is presented in Figs. 25 & 26.  
Estimation of in vivo antioxidants 
Preparation of tissue homogenate 
The isolated heart was washed and blotted in a filter paper. A10% tissue 
homogenate was prepared by using chilled 0.15M TRIS HCl (pH 7.4) buffer and 
centrifuged at 5000rpm for 5min. The clear supernatant liquid was used for the 
estimation TBARS, GSH and total protein. 
Estimation of lipid peroxidation (TBARS) 
The lipid peroxidation was estimated by the method described by Rajkumar 
D.V. et al. To 1mL of the tissue homogenate, 2.5mL of trichloroacetic acid (20%) 
were added and centrifuged.  2.5mL of 0.05M sulphuric acid and 3.5mL thiobarbituric 
acid were added to the supernatant liquid and incubated at 37
o
C for 30min.  It was then 
extracted with n-butanol. The intensity of the chromogen in the layer was measured at 
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530nm using UV spectrophotometer using n-butanol as blank. The results obtained are 
presented in the Table 17 and the graphical representation is presented in Fig. 27.  
Estimation of reduced glutathione (GSH) 
The reduced glutathione was estimated by the method described by Morn et 
al., (1979). 1mL of tissue homogenate was precipitated with 1mL of 10% TCA and 
was centrifuged to remove the precipitate. To 0.5mL of the supernatant added 2mL of 
0.6 mM 5,5’dithiobis-2-nitrobenzoic acid(DTNB) in 0.2M sodium phosphate and the 
total volume was made upto 3mL with 0.2M phosphate buffer (pH 8).  The absorbance 
was read out at 412nm. The results obtained are presented in Table 17 and the 
graphical representation of the same are presented in Fig 28. 
Histopathological studies 
The hearts isolated from each group were preserved in 10% formalin, 
processed and embedded in paraffin blocks. A four µm thick paraffin section were cut 
and stained with eosin and hematoxyin over a glass slide.  They were observed under 
light microscope and the pathological changes were recorded and presented in Fig. 29. 
Statistical Analysis 
All the data were expressed as standard error of mean (SEM).  Data of 
biochemical parameters were analyzd using one way ANOVA. Tukeys’s multiple 
range test was applied for post-hoc analysis. A value of p <0.001 was considered to be 
statistically significant. 
RESULTS AND DISCUSSION 
 The results obtained for the serum biochemical parameters are presented in 
Table 16. The creatine kinase (CK MB) and lactate dehydrogenase (LDB) values were 
determined. The ethanolic extract treated animals at a dose of 200mg/kg body weight 
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3.  Extract treated group (100mg/kg bw) -  the section of the heart of the extract 
treated animals showed  moderate pathology of the  myocardial structure. 
4. Extract treated group (200mg/kg bw) -  the section of the heart of the extract treated 
animals showed normal myocardial structure. 
 Doxorubicin used to treat a variety of malignancies such as leukemia, breast 
and ovarian cancer, Hodgkin and non Hogdgkin lymphomas. The major limitation is 
the development of cardiotoxicity. The adverse effects are dose dependent and recent 
studies have suggested that the doxorubicin induced toxicity involves the generation of 
ROS especially superoxide anion and hydrogen peroxide (1-3) which causes cellular 
damage. The cellular damage includes lipid peroxidation, protein cross linking, DNA 
fragmentation leading to cardiac dysfunction, apotosis and cardiomyopathy. Oxidative 
stress, lipid peroxidation and generation of free radical induced by doxorubicin leads 
to increased CK-MB, LDH, TBARS level. (4-7).  
Alleviation of toxicity can be achieved by administration of anitoxidants like 
vitamins E and C but their effects remain controversial (8-10). Ascorbic acid protects 
against lipid damage but not against protein damage (11). Hence a search for a good 
cadioprotective agent against doxorubicin induced cardiotoxicity.  
 The extract treated animals resulted in decrease of elevated endogenous CK-
MB, LDH and TBARS. The extract has been reported for the presence of tannins 
phenolics and flavonoids which may be attributed to the cardioprotective effect  
The extract also showed potential in vitro antioxidant activity by DPPH assay, 
nitric oxide scavenging activity and hydrogen peroxide scavenging activity. The 
mechanism behind the cardiotoxicity is free radical generation and oxidative stress. 
Since the plant extract also exhibited in vivo antioxidant activity. 
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Hence the result suggested that the cardioprotective effect against doxorubicin 
induced cardiotoxicty at 100mg/kg  & 200mg/kg of EGJ. 
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CO2, 95% air and 100% relative humidity. Maintenance cultures were passaged 
weekly, and the culture medium was changed twice a week. 
Cell treatment procedure 
 The monolayer cells were detached with trypsin-ethylenediamine tetraacetic 
acid (EDTA) to make single cell suspensions and viable cells were counted using a 
hemocytometer and diluted with medium containing 5% FBS to give final density of 
1x10
5
 cells/ml. one hundred microlitres per well of cell suspension were seeded into 
96-well plates at plating density of 10,000 cells/well and incubated to allow for cell 
attachment at 37
0
C, 5% CO2, 95% air and 100% relative humidity. After 24 h the cells 
were treated with serial concentrations of the test samples. They were initially 
dissolved in neat dimethylsulfoxide (DMSO) and diluted to twice the desired final 
maximum test concentration with serum free medium. Additional four, 2 fold serial 
dilutions were made to provide a total of five drug concentrations. Aliquots of 100 µl 
of these different drug dilutions were added to the appropriate wells already containing 
100 µl of medium, resulted the required final drug concentrations. Following drug 
addition the plates were incubated for 48 h at 37
0
C, 5% CO2, 95% air and 100% 
relative humidity. The medium containing without samples were served as control and 
triplicate was maintained for all concentrations.  
 After 48h of incubation, 15µl of MTT (5mg/ml) in phosphate buffered saline 
(PBS) was added to each well and incubated at 37
0
C for 4h. The medium with MTT 
was then flicked off and the formed formazan crystals were solubilized in 100µl of 
DMSO and then measured the absorbance at 570 nm using micro plate reader. The % 
cell inhibition was determined using the following formula.  
% cell Inhibition = 100- Abs (sample)/Abs (control) x100.  
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Nonlinear regression graph was plotted between % Cell inhibition and Log10 
concentration and IC50 was determined using Graph Pad Prism software. 
The results obtained for the MTT assay is presented in Table 18 and Figs. 30 & 31.                                 
RESULTS AND DISCUSSION 
           The results obtained for anticancer activity of 70% ethanolic extract of Justicia 
glauca on stomach adenocarcinoma cell lines (AGS) by MTT assay was presented in 
Table 18 and Figs. 30 & 31. 
           Table.18: Anticancer activity using stomach adenocarcinoma cell lines 
 by ethanolic extract of  Justicia glauca 
 
S. No 
Conc.in 
µg/mL 
Percentage 
cell 
inhibition 
IC 50 
1 31.25 11.717 
79.82 
µg/mL 
2 62.5 30.95 
3 125 78.542 
4 250 100 
5 500 100 
 
Fig. 30: Anticancer activity using stomach adenocarcinoma cell lines 
 by ethanolic extract of  Justicia glauca 
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             The amount of formazan  crystals produced  by MTT is directly proportional 
to the number of viable cells. A decrease in the cell count was observed as the 
concentration of the extract increases.. There was a dose depended increase in the 
cytotoxic activity. The extract at low concentration (31.25 µg/mL) showed 11.717 % 
cell inhibition and at high concentration (500 µg/mL) 100% cell inhibition. The 
inhibitory concentration (IC50) value was found to be 79.82µg. So the ethanolic extract 
of Justicia glauca possess significant anti cancer activity. 
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SECTION - D 
ANTIBACTERIAL ACTIVITY 
[83-87] 
Many higher plants accumulate extractable organic substances in quantities 
sufficient to be economically useful as pharmaceutical or antibiotics. Species of higher 
plants are much less surveyed for antibacterial activity. Plants have been a rich source 
of medicines because they produce wide array of bioactive molecules, most of which 
probably evolved as chemical defence against predation or infection. 
Alternative to available antibiotics for disease management are increasingly 
felt due to the increase in the resistance of bacterial isolates. This has necessitated the 
requirement of second and third line drug. Antibacterial active principles isolated from 
higher plants appear to be one of the important alternative approaches to contain 
antibiotic resistance and the management of disease. It is believed that plant based 
drugs cause less or no side effect when compared with synthetic antibiotics.  
Bacterial infection is any type of infection that is caused by bacterial (rather 
than a virus).Bacteria are very common in our bodies and in the world around us.Many 
of them are helful.Less than 1% of bacteria will actually makes us sick.when they do 
make sick it is called as “bacterial infection’’.  
Bacteria 
            The various micro-organisms used in the present study include Escherichia 
coli, Klebsiella pneumonia, Proteus mirabilis, Pseudomonas aeruginosa, 
Staphylococcus aureus, Staphylococcus albus and Streptocococcus pyogens. The 
purity of the cultures prior to their use was checked and confirmed by conventional 
cultures, morphological and biochemical methods. 
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Preparation of media 
Mull Hinton Agar media 
       Muller Hinton Agar (MH, Hi media) was used. The formula (gm/litre): Beef -2g, 
Caesin acid hydrolysate 17.5g, starch 1.5g and agar 17g. MH agar (38g) was weighed 
and dissolved in 1000ml of distilled water and adjusted to Ph 7.3±0.2. The medium is 
sterilized by autoclaving at 121°C for 15 minutes at 15psi pressure and was used for 
sensitivity tests. 
Blood agar media 
          The formula for the medium is nutrient substrate (heart extract and peptones) - 
20 g/liter; sodium chloride - 5g/L; agar-agar - 15g/L.  40g of the above powder was 
suspended in 1L of purified water and autoclaved for 15min at 121°C and cooled to 
45-50°C. The medium obtained was clear and yellowish-brown. To the above 
suspension 5-8% defibrinated blood was added and mixed. The medium was poured 
into petridishes. This medium was used for studying antibacterial activity against 
Streptococcus pyogens.  
Preparation of bacterial cultures 
          Few colonies of the bacterial strains selected for study were picked from the 
agar slopes and inoculated into 4ml peptone water in a test tube and incubated for 2-4 
hours to produce suspensions. The suspension were then diluted with saline, if 
necessary to a density visually equivalent to that of standard prepared by adding 0.5ml 
of 1% barium chloride to 99.5ml of 1% sulphuric acid. These suspensions were used 
for seeding. 
Drugs  
Amikacin (30µg/disc) was used as standard 
Ethanolic extract of Justicia glauca (EJG). 
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Preparation of extract 
    The plant extract was dissolved in DMSO to get a concentration of 10mg/mL. 
Preparation of agar plates 
      The media (20mL) was introduced aseptically into sterilized petridishes and 
the petridishes were swirled until the agar begins to set. 
Disc Diffusion technique 
           The pathogenic strains were then seeded evenly all over the plate on the 
prepared MH agar medium by streaking the plate with the help of a sterile swab and 
allowed to dry. 
Test procedure 
           The plain sterile discs of 6mm diameter were obtained from Hi Media. The 
discs were then impregnated with different concentrations of the methanolic extract of 
J. glauca dissolved in DMSO. 30µg of amikacin discs was used as a standard. The 
standard, extract and DMSO discs were then placed on the seeded medium plates. The 
plates were then incubated at 37°C for 24h. The results were read by the presence or 
absence of zone of inhibition. The zone of inhibition was then measured and the 
activity of different concentration of extracts was compared with the standard. The 
results are tabulated in Table. 19. The zone of inhibition obtained in the antibiotic disc 
diffusion against various microorganisms are presented in Table 20. The 
photographical representations of the antibacterial activity against various organisms 
are presented in Figs. 32 to 35. 
Experimental procedure for Streptococcus pyogens 
The procedure adopted above was followed except the medium used was blood 
agar medium 
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RESULTS AND DISCUSSION 
Minimum inhibitory concentration (MIC) 
            MIC is the concentration of antimicrobial required to inhibit the growth of a 
particular bacterial isolate in vitro. Clinically the MIC is used to assign an organism to 
a susceptibility category. The results obtained for MIC for various organisms are 
presented in Table 19. 
Table 19: MIC of 70%ethanolic extract of J. glauca 
against various microorganisms 
 
 
S. 
No 
 
Name of the organism 
Minimum 
inhibitory 
concentration (in 
mg/disc) 
1. Escherichia coli 1.5 
2. Klebsiella pneumoniae 1.5 
3. Proteus mirabilis 1.5 
4. Staphylococcus aureus 1.5 
5 Staphylococcus albus 1.5 
6 Pseudomonas aeruginosa 1.5 
7 Streptococcus pyogens 1.5 
 
Table 20: Antibiotic disc diffusion assay against 
various microorganism 
 
S. 
No 
Name of the organism 
Zone of inhibition (in mm)* 
Standard 
70%ethanolic 
extract 
1. Escherichia coli 26.0 ±  0.0 18.0 ±  0.5 
2. Klebsiella pneumonia 26.0 ±  1.0 22.0 ±  0.5 
3. Proteus mirabilis 25.0 ±  0.0 21.0±  0.5 
4. Staphylococcus aureus 27.0 ±  0.5 22.0 ±  0.5 
5. Staphylococcus albus 26.0 ±  0.0 22.0 ±  0.5 
6. Pseudomonas aeruginosa 25.0 ±  0.0 20.0 ±  0.5 
7. Streptococcus pyogens 28.0 ± 0.0 14.0  ± 0.5 
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SECTION - E 
ANTI FUNGAL ACTIVITY 
[88-91]
 
Disc diffusion method 
Inoculum preparation 
The fungal colony to be tested was grown in potato dextrose agar slant at 35
° 
C 
to induce the conidium and sporangiospore formation. After 7-10 days of incubation 
with well grown spores, the culture was taken for testing. 5ml of 0.85% sterile saline 
was added to the culture tube and the suspension were made by gently probing the 
colonies with the tip of Pasteur pipette. With the help of sterile pipettes, the saline with 
conidia was transferred in to a sterile screw cap tube. The tube was then vortexed for 
30sec to 1min and allowed  to stand at room temperature for 5 to 10min for the heavier 
particles to settle down. The upper homogenous suspensions were collected and the 
densities of the conidial suspensions were read and adjusted the optical density (OD) 
to be between 0.09 and 0.11 for Aspergillus species, 0.15 to 0.17 for Fusarium species 
by using UV Visisble spectrophotometer at 530nm. The suspensions were diluted 1:50 
in RPMI 1640 medium. The final concentration of the conidia was 0.2 – 1 X 10
4 
cfu/mL.  
Medium 
Disc diffusion test was performed on Muller-Hinder agar plates supplemented 
with 2% glucose and 0.5µg / L Methylene blue. 
Preparation of extract 
The plant extract of Justicia glauca was dissolved in DMSO solution to produced final 
concentration 10mg, 15mg, 20mg. 
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Procedure 
The entire dried agar surface was evenly streaked in three different directions 
with a sterile cotton swap dipped into the inoculum suspension. The plate was allowed 
to dry for 20min. Using a pair of flame sterilized forceps the antifungal discs were 
applied on to the surface of the inoculated plates. The plates were incubated at 35
°
C 
for 48h. The plates were read at 24h and 48h.  
Minimum inhibitory concentration (MIC) 
The minimum inhibitory concentration was defined as the lowest concentration 
of extract  that allows no more than 20% growth of microbes after incubation on SDA 
media at 37
°
C for 24h. The results obtained for the antifungal activity is tabulated in 
Table 21 and the pictorial representations are presented in Figs. 36 to 39.  
RESULTS AND DISCUSSION 
The results obtained for antifungal activity is presented in Table 21. From the table it 
can be seen that the Minimum inhibitory concentration for Aspergillus fumigatus and  
Candida albicans was 8mg/disc while it was 10mg/disc for Aspergillus flavus and for 
Epidermophyton floccosum it was found to be 12mg/disc. 
Table 21: Minimum Inhibitory concentration of the  
ethanolic extract of J. glauca against various fungi 
 
  S. No Name of the fungal isolate 
MICin (in  
mg/disc) 
 
1. Epidermophyton floccosum 12 
2. Aspergillus flavus 10 
3. Aspergillus fumigates 08 
4. Candida albicans 08 
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CHAPTER-8 
SUMMARY AND CONCLUSION 
  There are many unknown plants with high medicinal value still not been 
recognised for their importance. They have not been brought to the light of scientific 
world. This dissertation covers pharmacognostical, phytochemical and 
pharmacological studies on the commonly available medicinal plant Justicia glauca  
belonging to the family Acanthaceae. 
  Pharmacognostical parameters have been determined on the leaves in order to 
substantiate and identify the plant for future work. 
  Preliminary phytochemical screening carried out on the plant powder and 
extracts confirmed the presence of flavonoids, phenols, tannins, sterols, alkaloids and 
carbohydrates  The determination of total phenolics (58.06 mg/g), total flavanoid 
content (29.35mg/g) and total vitamin C content (15.97mg/g) confirms the significant 
concentration of these phytoconstituents in the ethanolic extract of Justicia glauca . 
The TLC and HPTLC studies on ethanolic extract of Justicia glauca will help us in 
the fingerprinting the profile of the plant for future reference. 
  The pharmacological screening confirms 
  The ethanolic extract of Justicia glauca have exhibited radical scavenging 
activity by DPPH assay and hydrogen peroxide method shown potent 
antioxidant activity.  
 Significant cardioprotective activity at 100mg/kg of S (p<0.001), 200 mg/kg 
of EJS (p<0.001) against Doxorubicin induced cardiotoxicity in rats and the in 
vivo antioxidant activity of these extracts may be ascribed for this 
cardioprotective activity which is confirmed by elevation of GSH 
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(p<0.001)and reduction of TBARS (p<0.001) in the tissue parameters of the 
treated animals. 
 Significant anti-bacterial activity exhibited by ethanolic extract (1.5mg/ disc) 
against Escherichia coli, Klebsiella pneumonia, Proteus mirabilis, 
Staphylococcus aureus, Staphylococcus albus and Pseudomonas aeruginosa. 
 Significant anti-fungal activity exhibited by ethanolic extract (8/ disc) against 
Aspergillus flavus and Candida albicans.  
   It was evident from the phytochemical studies of this plant, that substantial 
amount of phenols and flavanoids were present in these extracts which exhibited 
significant invitro antioxidant activity. 
  Cardiomyopathy may be due to viruses, amyloidosis, diabetes, thyroid 
diseases, medications such as chemotheraphy drugs (Doxorubicin, Donorubicin, etc). 
Though many synthetic cardioprotective agents are available, herbal drugs are 
preferred for their safety and efficacy. Cardiotoxicity was induced in the animal 
model using Doxorubicin (antineoplastic agent). Doxorubicin cause oxidative stress 
leads to cardiac tissue damage at 15mg/kg i.p in rats. The extract has shown 
significant cardioprotective action and anti-bacterial activity against the pathogenic 
organisms.  
  The ethanolic extract of Justicia glauca  may serve as a lead medicinal plant to 
synthesise various semi-synthetic drugs to treat various life threatening diseases like 
congestive heart failure, cancer, bacterial. fungal infections. 
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